Management of Multinodular Thyroid Gland with Worrisome Nodules
Immediate Next Steps
Fine-needle aspiration biopsy (FNAB) should be performed on the worrisome nodule in the left lobe (0.88 x 0.53 cm with internal vascularity) and the calcified focus (0.62 x 0.54 cm) as the highest priority. 1
The ultrasound findings reveal several concerning features that warrant immediate investigation:
- Multinodular appearance with heterogeneous texture
- Overall increased vascularity
- A left lobe nodule with internal vascularity (0.88 x 0.53 cm)
- A calcified focus in the left lobe (0.62 x 0.54 cm)
Diagnostic Approach
Thyroid Function Tests:
- Measure TSH, free T4, and free T3 to assess thyroid function status
- If TSH is subnormal, consider radioisotope scanning before biopsy 1
Serum Calcitonin Measurement:
- Essential to rule out medullary thyroid cancer
- Has higher sensitivity than FNAC for detecting medullary thyroid cancer 1
Ultrasound-Guided FNAB:
- Target the nodule with internal vascularity (0.88 x 0.53 cm)
- Target the calcified focus (0.62 x 0.54 cm)
- Calcifications within thyroid nodules significantly increase malignancy risk (59.2% of nodules with calcifications were found to be malignant in one study) 2
Consider Additional Imaging:
Rationale for FNAB
FNAB is indicated based on several high-risk features:
- The presence of internal vascularity in the left lobe nodule
- The calcified focus in the left lobe (calcification is associated with higher risk of malignancy)
- Heterogeneous texture with multinodular appearance
While the nodules are smaller than 1 cm (typically the size threshold for biopsy), the presence of suspicious sonographic features warrants FNAB regardless of size 1.
Management Algorithm Based on FNAB Results
If FNAB Shows Malignancy:
Surgical Management:
Post-Surgical Evaluation:
- Consider radioiodine ablation based on risk stratification
- TSH suppression with levothyroxine 3
If FNAB Shows Indeterminate Results:
- Consider molecular testing to further stratify risk
- Surgical consultation for possible diagnostic lobectomy
- Close follow-up with repeat ultrasound in 3-6 months
If FNAB Shows Benign Results:
- Regular ultrasound monitoring:
- Initial follow-up at 6-12 months
- Then annually if stable 1
- Repeat FNAB if significant growth occurs or new suspicious features develop
Important Considerations
- The presence of calcification significantly increases malignancy risk, with studies showing up to 75.7% risk of malignancy in solitary nodules with calcification 2
- Internal vascularity is another concerning feature that increases suspicion for malignancy
- Even with benign FNAB results, close follow-up is essential as false negatives can occur, particularly with calcified nodules 2
- Avoid relying solely on reassuring FNAB results when clinical and sonographic findings are worrisome 1
Pitfalls to Avoid
- Dismissing calcifications as incidental findings (they significantly increase malignancy risk)
- Neglecting to measure calcitonin (could miss medullary thyroid cancer)
- Failing to have cytology reviewed by a pathologist with expertise in thyroid disorders
- Delaying surgical consultation when there are multiple concerning features
The presence of both a nodule with internal vascularity and a calcified focus in the left lobe represents a significant risk for malignancy that requires prompt evaluation with FNAB, regardless of the small size of these nodules.